First quarter 2024 revenue
- Solid business growth in the first quarter of 2024: revenue up 7.4%
- All regions and business segments contributing to growth
- Refinancing Plan well underway in the first quarter:
o AMF exemption obtained by Predica
o First tranche of asset disposals completed, raising €268 million, more than quarter of the total disposal plan
o In the Combined General Meeting of Shareholders of 26 March 2024, the capital in-crease was approved by a very large majority
- 2024 objectives confirmed: organic revenue growth of over 5% and stable EBITDA* in value
Sophie Boissard, CEO of Clariane, said:
“The Group’s performance in the first quarter confirmed our strong operational momentum over the recent period, across all of our business segments and in all re-gions in which Clariane operates. In particular, the Group’s average occupancy rate in its Long-Term Care segment rose close to 90% in March 2024.
The Group is prioritising more than ever the implementation of the refinancing plan announced on 14 November 2023. A key milestone was reached on 26 March, in our Combined General Meeting of Shareholders, when 98% of votes were cast in favour of the capital increase. We hope to meet the other prior requirements for carrying out the capital increase – gaining regulatory approval in particular – in the coming weeks. At the same time, after selling certain real-estate assets in the Netherlands in the first quar-ter along with all of our UK operations, we are continuing to make progress with our disposal plan, with the aim of reducing our debt and leverage.
2024 will therefore be an important transitional year for the Group. The dedication of our staff members, along with good momentum in our various business segments and geographies, means that we can look ahead to the coming year with confidence.”
-----
Clariane’s revenue in the first quarter of 2024 amounted to €1,308 million, up 7.4% on a re-ported basis and at constant scope and exchange rates. Across the Group as a whole, the occupancy rate in the Long-Term Care segment rose 1.9
points to 89.6% in the first quarter of 2024. At 31 March 2024, the network consisted of 1,235 facilities as opposed to 1,195 a year earlier, representing almost 92,000 beds versus around 91,000 at 31 March 2023.
Reported revenue growth was supported by:
- growth in business volumes, which had a net positive impact of €47 million (higher occupancy rate in mature facilities, additional capacity coming onstream);
- price increases, which had a positive impact of €43 million, particularly in France;
- a neutral effect from changes in scope.
Disclaimer :
This press release does not constitute, and shall not be deemed to constitute, an offer to the public or an offer to buy or the solicitation of public interest in an offer to the public, nor shall there be any sale of securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful absent registration or approval under the securities laws of such state or jurisdiction. The distribution of this document may be subject to specific restrictions in certain countries. Persons in possession of this document are required to inform themselves of and to observe any such local restrictions. A prospectus relating to the capital increase will be submitted by Clariane S.E. to the Autorité des marchés financiers for approval prior to the effective launch of the capital increase. All forward-looking statements included in this document speak only as of the date of this press release. Clariane S.E. undertakes no obligation and assumes no responsibility to update the information contained herein beyond what is required by applicable regulations. In this press release, unless otherwise indicated, all changes are expressed on a year-on-year basis (2023/2022), and at constant scope and exchange rates. The main alternative performance indicators (APIs), such as EBITDA, EBIT, net debt and financial leverage, are defined in the Universal Registration Document available on the company's website at www.clariane.com.
